All News

Biotech and pharma companies have overtaken the technology sector in the European Commission’s annual scoreboard of R&D investment for the first time.

With the French Senate ratifying the London Agreement on patent translation, technology companies can look to a much cheaper future.

Economic impact must be embedded into research policy, says Philip Esler, Chief Executive of the UK’s Arts and Humanities and Research Council.